Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials

Abstract

Objective:

Individual clinical trials have demonstrated benefits of donepezil in patients with severe Alzheimer's disease (AD). Data were pooled from three randomized, placebo-controlled trials of donepezil for severe AD to further evaluate treatment effects and overall tolerability/safety.